Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C68H106N11O15 |
| Molecular Weight | 1317.6339 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 12 / 12 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]([C@@H](C)CC)([C@@H](CC(=O)N1CCC[C@@]1([H])[C@H](OC)[C@@H](C)C(=O)N[C@H](C)[C@@H](O)C2=CC=CC=C2)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C(=O)OCC3=CC=C(NC(=O)[C@H](CCCNC(N)=O)NC(=O)[C@@H](NC(=O)CCCCCN4C(=O)CC([He])C4=O)C(C)C)C=C3)C(C)C
InChI
InChIKey=ERROR
Vedotin fragment (Monomethyl auristatin E, MMAE; SGD-1010) is a synthetic derivative of dolastatin 10 and functions as a potent mitotic inhibitor by inhibiting tubulin polymerization. MMAE is widely used as a cytotoxic component of antibody-drug conjugates (ADCs) to treat several different cancer types. MMAE is a potent radiosensitizer. MMAE radiosensitization can be localized to tumors by targeted activatable cell-penetrating peptides.
Approval Year
Sample Use Guides
Vedotin fragment (MMAE) was incubated at 1-1000 nM with cultured primary human hepatocytes for 72 h, and CYP1A2, CYP2B6, and CYP3A4 mRNA expression was assessed by quantitative reverse transcription-polymerase chain reaction and CYP-specific probe substrate by liquid chromatography coupled with mass spectrometry, along with microtubule disruption by immunofluorescence staining using anti-β-tubulin antibody and imaging. MMAE up to 10 nM had no significant effect on CYP1A2, CYP2B6, and CYP3A4 mRNA expression and activity, whereas at higher concentrations of 100- and 1000-nM MMAE, the CYP mRNA expression and activity were diminished substantially. At the clinical dose, the concentration of MMAE was 7 nM which did not show any significant CYP suppression or microtubule disruption in hepatocytes.
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Official Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C67422
Created by
admin on Sat Dec 16 13:59:19 GMT 2023 , Edited by admin on Sat Dec 16 13:59:19 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
Q3606FDE0B
Created by
admin on Sat Dec 16 13:59:19 GMT 2023 , Edited by admin on Sat Dec 16 13:59:19 GMT 2023
|
PRIMARY | |||
|
C152842
Created by
admin on Sat Dec 16 13:59:19 GMT 2023 , Edited by admin on Sat Dec 16 13:59:19 GMT 2023
|
PRIMARY | |||
|
CHEMBL2364667
Created by
admin on Sat Dec 16 13:59:19 GMT 2023 , Edited by admin on Sat Dec 16 13:59:19 GMT 2023
|
PRIMARY | |||
|
300000044630
Created by
admin on Sat Dec 16 13:59:19 GMT 2023 , Edited by admin on Sat Dec 16 13:59:19 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD
